Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans

European Journal of Endocrinology

Volumn 169, Issue 4, 2013, Pages 453-462

  Chamberland, John P ^a,b   Berman, Reena L ^a,b   Aronis, Konstantinos N ^a,b,c   Mantzoros, Christos S ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Division of Endocrinology Diabetes and Hypertension   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN; CHEMOKINE RECEPTOR CCR1; INSULIN; LEPTIN; METRELEPTIN; PLACEBO; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; EX VIVO STUDY; FEMALE; FOOD DEPRIVATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIVER; MALE; NORMAL HUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SUBCUTANEOUS TISSUE; TISSUE MICROARRAY; TISSUE SPECIFICITY;

ADULT; ANIMALS; CHEMOKINES; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; EATING; ENERGY METABOLISM; FASTING; FEMALE; HUMANS; INSULIN; LEPTIN; LIVER; MICE; PANCREAS; RECEPTORS, CHEMOKINE; RNA, MESSENGER; YOUNG ADULT;

EID: 84884839429     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0098     Document Type: Article

References (42)

1. Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, John H, Richter R, Schleuder D, Meyer M & Forssmann WG. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Letters 2003 555 495-499. (doi:10.1016/S0014-5793(03)01312-7) (Pubitemid 37532599)
2. Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M, Teng M, Duvic M & Chandraratna RA. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. Journal of Investigative Dermatology 1997 109 91-95. (doi:10.1111/1523-1747.ep12276660) (Pubitemid 27305655)
3. Ernst MC & Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends in Endocrinology and Metabolism 2010 21 660-667. (doi:10.1016/j.tem.2010.08.001)
4. Parlee SD, Ernst MC, Muruganandan S, Sinal CJ & Goralski KB. Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-a. Endocrinology 2010 151 2590-2602. (doi:10.1210/en.2009-0794)
5. Kralisch S, Weise S, Sommer G, Lipfert J, Lossner U, Bluher M, Stumvoll M & Fasshauer M. Interleukin-1b induces the novel adipokine chemerin in adipocytes in vitro. Regulatory Peptides 2009 154 102-106. (doi:10.1016/j. regpep.2009.02.010)
6. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, Morrison S, Carless M, Dyer TD, Cole SA et al. Chemerin, a novel adipokine in the regulation of angiogenesis. Journal of Clinical Endocrinology and Metabolism 2010 95 2476-2485. (doi:10.1210/jc.2010-0042)
7. Kaur J, Adya R, Tan BK, Chen J & Randeva HS. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochemical and Biophysical Research Communications 2010 391 1762-1768. (doi:10.1016/j.bbrc.2009.12.150)
8. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S & Sinal CJ. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 2007 282 28175-28188. (doi:10.1074/jbc.M700793200) (Pubitemid 47529521)
9. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M & Sasaki S. Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochemical and Biophysical Research Communications 2007 362 1013-1018. (doi:10.1016/j.bbrc. 2007.08.104) (Pubitemid 47390675)
10. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K & Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007 148 4687-4694. (doi:10.1210/en.2007-0175) (Pubitemid 47481514)
11. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. Journal of Clinical Endocrinology and Metabolism 2009 94 3085-3088. (doi:10.1210/jc.2008-1833)
12. Weigert J, Neumeier M,Wanninger J, Filarsky M, Bauer S,Wiest R, Farkas S, Scherer MN, Schaffler A, Aslanidis C et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology 2010 72 342-348. (doi:10.1111/j.1365-2265.2009.03664.x)
13. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J & Clement K. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism 2010 95 2892-2896. (doi:10.1210/jc.2009-2374)
14. Tonjes A, Fasshauer M, Kratzsch J, Stumvoll M & Bluher M. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 2010 5 e13911. (doi:10.1371/journal.pone.0013911)
15. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, Iida K, Okimura Y, Kaji H, Kitazawa S et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters 2008 582 573-578. (doi:10.1016/j.febslet.2008.01.023)
16. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425-432. (doi:10.1038/372425a0) (Pubitemid 24365442)
17. Kelesidis T, Kelesidis I, Chou S & Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Annals of Internal Medicine 2010 152 93-100. (doi:10.7326/0003-4819-152-2-201001190- 00008)
18. Mantzoros CS. Role of leptin in reproduction. Annals of the New York Academy of Sciences 2000 900 174-183. (doi:10.1111/j.1749-6632.2000.tb06228.x) (Pubitemid 30251467)
19. Hamnvik OP, Liu X, Petrou M, Gong H, Chamberland JP, Kim EH, Christophi CA, Kales SN, Christiani DC & Mantzoros CS. Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study. Metabolism 2011 60 987-993. (doi:10.1016/j.metabol.2010.09.009)
20. Chan JL & Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005 366 74-85. (doi:10.1016/S0140-6736(05)66830-4) (Pubitemid 40956533)
21. Hill JW, Elias CF, Fukuda M, Williams KW, Berglund ED, Holland WL, Cho YR, Chuang JC, Xu Y, Choi M et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metabolism 2010 11 286-297. (doi:10.1016/j.cmet.2010.03. 002)
22. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A & Mantzoros CS. Recombinant human leptin in women with hypothalamic amenorrhea. New England Journal of Medicine 2004 351 987-997. (doi:10.1056/NEJMoa040388) (Pubitemid 39166262)
23. Chou SH, Chamberland JP, Liu X, Matarese G, Gao C, Stefanakis R, Brinkoetter MT, Gong H, Arampatzi K & Mantzoros CS. Leptin is an effective treatment for hypothalamic amenorrhea. PNAS 2011 108 6585-6590. (doi:10.1073/pnas.1015674108)
24. Sienkiewicz E, Magkos F, Aronis KN, Brinkoetter M, Chamberland JP, Chou S, Arampatzi KM, Gao C, Koniaris A & Mantzoros CS. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism: Clinical and Experimental 2011 60 1211-1221. (doi:10.1016/j.metabol.2011.05.016)
25. Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, De Rosa V, Perna F, Fontana S & Mantzoros CS. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. PNAS 2006 103 8481-8486. (doi:10.1073/pnas.0505429103) (Pubitemid 43838481)
26. Chan JL, Wong SL & Mantzoros CS. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity. Clinical Pharmacokinetics 2008 47 753-764. (doi:10.2165/00003088-200847110-00006)
27. Moon HS, Chamberland JP, Diakopoulos KN, Fiorenza CG, Ziemke F, Schneider B & Mantzoros CS. Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans. Diabetes Care 2010 34 132-138. (doi:10.2337/dc10-0518)
28. Chakaroun R, Raschpichler M, Kloting N, Oberbach A, Flehmig G, Kern M, Schon MR, Shang E, Lohmann T, Dressler M et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism: Clinical and Experimental 2012 61 706-714. (doi:10.1016/j.metabol. 2011.10.008)
29. El-Mesallamy HO, El-Derany MO & Hamdy NM. Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease. Diabetic Medicine 2011 28 1194-1200. (doi:10.1111/j.1464-5491.2011.03353.x)
30. Vamvini MT, Aronis KN, Chamberland JP & Mantzoros CS. Energy deprivation alters in a leptin-and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males. Journal of Clinical Endocrinology and Metabolism 2011 96 3416-3423. (doi:10.1210/jc. 2011-1665)
31. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brezillon S, Tyldesley R, Blanpain C, Detheux M et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine 2003 198 977-985. (doi:10.1084/jem. 20030382) (Pubitemid 37248614)
32. Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, Heutling D, Lewandowski KC, O'Hare JP, Lehnert H & Randeva HS. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009 58 1971-1977. (doi:10.2337/db08-1528)
33. Loboda A, Kraft WK, Fine B, Joseph J, Nebozhyn M, Zhang C, He Y, Yang X, Wright C, Morris M et al. Diurnal variation of the human adipose transcriptome and the link to metabolic disease. BMC Medical Genomics 2009 2 7. (doi:10.1186/1755-8794-2-7)
34. Scheer FA, Chan JL, Fargnoli J, Chamberland J, Arampatzi K, Shea SA, Blackburn GL & Mantzoros CS. Day/night variations of high-molecular-weight adiponectin and lipocalin-2 in healthy men studied under fed and fasted conditions. Diabetologia 2010 53 2401-2405. (doi:10.1007/s00125-010-1869-7)
35. Mullington JM, Chan JL, Van Dongen HP, Szuba MP, Samaras J, Price NJ, Meier-Ewert HK, Dinges DF & Mantzoros CS. Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. Journal of Neuroendocrinology 2003 15 851-854. (doi:10.1046/j.1365-2826.2003.01069.x) (Pubitemid 37038610)
36. Kalsbeek A, Ruiter M, La Fleur SE, Cailotto C, Kreier F & Buijs RM. The hypothalamic clock and its control of glucose homeostasis. Progress in Brain Research 2006 153 283-307. (Pubitemid 44107422)
37. Mantzoros CS, Cramer DW, Liberman RF & Barbieri RL. Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome. Human Reproduction 2000 15 539-544. (doi:10.1093/humrep/15.3.539) (Pubitemid 30142358)
38. Vaisman N, Schattner A & Hahn T. Tumor necrosis factor production during starvation. American Journal of Medicine 1989 87 115. (doi:10.1016/S0002-9343(89)80497-8) (Pubitemid 19179424)
39. Vaisman N & Hahn T. Tumor necrosis factor-a and anorexia-cause or effect? Metabolism 1991 40 720-723. (doi:10.1016/0026-0495(91)90090-J)
40. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H & Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. European Journal of Haematology 1995 54 1-8. (doi:10.1111/j.1600- 0609.1995.tb01618.x)
41. Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N & Flier JS. Leptin concentrations in relation to bodymass index and the tumor necrosis factor-a system in humans. Journal of Clinical Endocrinology and Metabolism 1997 82 3408-3413. (doi:10.1210/jc.82.10.3408) (Pubitemid 27419096)
42. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine & Growth Factor Reviews 1996 7 231-240. (doi:10.1016/S1359-6101(96) 00026-3) (Pubitemid 27200307)